ACCREDITATION STATEMENT

Focal Therapy
2022 Annual Meeting – Live
September 23 – 24, 2022
Los Angeles, CA

2022 Annual Meeting – Enduring
Date of CE Release: 09-25-2022
Date of CE Expiration: 11-25-2022
Location: Online

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Focal Therapy. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) Credit Designation Statement

Amedco LLC designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Amedco LLC designates this enduring material for a maximum of 13.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives – After Attending This Program You Should Be Able To
1. Describe the rationale, the latest evidence on oncological and functional outcomes, surveillance strategies and management of the complications of focal therapy
2. Describe and perform steps of transperineal interventions and treatment planning for focal therapy using different modalities.
3. Describe the indications, preoperative evaluation, surgical steps/procedure, and expected patient outcomes for various minimally invasive operations for BPH

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.